Serosep
Private Company
Funding information not available
Overview
Serosep is a long-established, privately-held diagnostics company headquartered in Limerick, Ireland, with a diversified portfolio across human and veterinary health. Its core business involves manufacturing and distributing diagnostic tests and instruments, with notable strengths in molecular diagnostics for gastroenteritis (EntericBio) and a proprietary line of histology specimen containers (Histopot). The company operates through a combination of its own branded products and a partnership model distributing third-party instrumentation, serving clinical, environmental, and research laboratories globally.
Technology Platform
Applied expertise across multiple diagnostic modalities including real-time PCR assay development, stabilized reagent formulation, and high-quality consumable manufacturing. Not a single platform but integrated capabilities in molecular, serological, and histology workflows.
Opportunities
Risk Factors
Competitive Landscape
Serosep competes in a fragmented but competitive diagnostics market. It faces large multinational corporations (e.g., Roche, Abbott, bioMérieux) in molecular and serology, and specialized consumables manufacturers in histology. Its strategy is to compete on product reliability, workflow efficiency, customer support, and its specialist reputation rather than solely on technological novelty.